Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Study points to potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease

July 20, 2020
Genetics Glaucoma Neuroscience Optic Nerve Disorders
Basic Research
Grantee

Researchers at Vanderbilt University Medical Center have shown for the first time that when one optic nerve in the eye is damaged, as in glaucoma, the opposite optic nerve comes to the rescue by sharing its metabolic energy.

In doing so, however, the undamaged optic nerve becomes vulnerable to further metabolic stress, which could explain why the neurodegeneration observed in this and other diseases spreads between brain regions.

The report suggests a potential new approach to treating neurodegenerative diseases like glaucoma and Alzheimer’s disease by beefing up the metabolic resources of the involved neurons.

Read more at Vanderbilt University Medical Center Reporter